the future of medicine

harnessing the power of cells
We accelerate discovery and translation of cell therapies, to improve quality of life through regenerative medicine.



Stem Cells

Regenerating damaged organs, tissues, and cells.

Cancer Immunotherapy

Leveraging the immune system to fight cancer.

Our Cell Therapy Discovery Engine

relieving R&D bottlenecks and simplifying manufacturing pipelines
Our Discovery Engine provides an unprecedented window into cell-driven biology.

Miniaturization

Microfluidic-enabled technology allows inputs to be combinatorially multiplexed to generate tens of thousands of experimental conditions in parallel.

Automation

End-to-end assay automation, enabled by cloud-directed robotics increases experimental reproducibility, performance whilst reducing human intervention.

computation

Multi-dimensional, single-cell resolution data is rapidly turned into actionable results or cycled back through the process for enhanced optimization.

Current Operations

Powering both partner and internal programs

Partner Programs

Our Discovery Engine is enabling leading biotech and pharmaceutical companies to develop novel and optimal cell-based products and processes, simplifying manufacturing, reducing time to market, and improving clinical outcomes.

Internal Programs

Our internal, CIRM-funded program focuses on developing clinical grade iPSC-derived dopaminergic neurons as a curative cell therapy for the more than 10 million patients suffering from Parkinson’s disease.





defining new stem cell differentiation strategies operational
Reducing cost of goods sold operational
Preclinical drug testingoperational
Probing complex, combinatorial biologyoperational
Immuno-oncologyvalidating
Please see our list of publications for more technical details. Our FAQ may also help.

Developing cell-based Products or Assets?

accelerate your R&D today
Let's Collaborate

Thoughts & News

A window into our approach from our blog and our latest news

Behind The Curtain

Jul 5 | Brendan Griffen

Play Nice With The Engineers

Apr 11 | Drew Titmarsh

Astronomy & Biology

Feb 28 | Brendan Griffen

Economically Viable Biology

Feb 6 | Drew Titmarsh

Deep Blue Biology

Jan 4 | Brendan Griffen

Designing Reliability

Nov 4 | Drew Titmarsh

Small Optimizations, Big Results

Oct 17 | Drew Titmarsh

Scaled Wins CIRM DISC-02 Grant

June 29, 2017 We're excited to announce that CIRM, California's stem cell agency, awarded us with a 2-year, ~$700k DISC-02 discovery grant. Together with collaborators at The Scripps Research Institute, we will deploy our technology to produce optimized, clinical grade manufacturing processes for dopaminergic neuron cells with the goal of treating patients with Parkinson's disease. Learn More
Would you like to be updated?

subscribe to our periodic newsletter

subscribe

Our Partners

partners who share our vision

Contact

Tel: +1 (415) 655 1868

Email: mail@scaledbiolabs.com

Fill out my online form.